Abstract
Philosophers have been trying to solve the mind-body problem for hundreds of years. Consciousness is the core of this problem: How do subjective conscious sensations, perceptions, feelings, and thoughts arise out of objective physical brain activities? How is this subjective conscious world in causal interaction with the objective sensory and motor mechanisms of the brain and the body? Although we witness the seamless interaction of the mental and the physical worlds in our everyday lives, no scientific theory can yet fully describe or explain it. The hard problem of consciousness, the question why and how any brain activity should be accompanied by any subjective experiences at all, remains a mystery and a challenge for modern science. Anesthesia offers a unique and safe way to directly manipulate the state of consciousness and can, thus, be used as a tool in consciousness research. With neuroimaging, such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) performed at different states of consciousness, it is possible to visualize the state-related changes and pinpoint the brain structures or neural mechanisms related to changes in consciousness. With these tools, neurosciences now show promise in disentangling the eternal enigma of human consciousness. In this article, we will review the recent advancements in the field.
Keywords: Consciousness, anesthesia, neuroimaging, positron emission tomography, magnetic resonance imaging, responsiveness, connectedness.
Current Pharmaceutical Design
Title:Harnessing Anesthesia and Brain Imaging for the Study of Human Consciousness
Volume: 20 Issue: 26
Author(s): Jaakko W. Langsjo, Antti Revonsuo and Harry Scheini
Affiliation:
Keywords: Consciousness, anesthesia, neuroimaging, positron emission tomography, magnetic resonance imaging, responsiveness, connectedness.
Abstract: Philosophers have been trying to solve the mind-body problem for hundreds of years. Consciousness is the core of this problem: How do subjective conscious sensations, perceptions, feelings, and thoughts arise out of objective physical brain activities? How is this subjective conscious world in causal interaction with the objective sensory and motor mechanisms of the brain and the body? Although we witness the seamless interaction of the mental and the physical worlds in our everyday lives, no scientific theory can yet fully describe or explain it. The hard problem of consciousness, the question why and how any brain activity should be accompanied by any subjective experiences at all, remains a mystery and a challenge for modern science. Anesthesia offers a unique and safe way to directly manipulate the state of consciousness and can, thus, be used as a tool in consciousness research. With neuroimaging, such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) performed at different states of consciousness, it is possible to visualize the state-related changes and pinpoint the brain structures or neural mechanisms related to changes in consciousness. With these tools, neurosciences now show promise in disentangling the eternal enigma of human consciousness. In this article, we will review the recent advancements in the field.
Export Options
About this article
Cite this article as:
Langsjo W. Jaakko, Revonsuo Antti and Scheini Harry, Harnessing Anesthesia and Brain Imaging for the Study of Human Consciousness, Current Pharmaceutical Design 2014; 20 (26) . https://dx.doi.org/10.2174/13816128113196660650
DOI https://dx.doi.org/10.2174/13816128113196660650 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Baclofen-induced Encephalopathy in Patients with End-stage Kidney Disease – A Case Series
New Emirates Medical Journal Silencing the Brain May be Better than Stimulating it. The GABA Effect
Current Pharmaceutical Design Therapeutic Trials in Human Transmissible Spongiform Encephalopathies: Recent Advances and Problems to Address
Infectious Disorders - Drug Targets Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia
Central Nervous System Agents in Medicinal Chemistry Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges
Current Medicinal Chemistry Vascular Cognitive Disorder: A Diagnostic and Pharmacological Treatment Updating
Current Psychopharmacology Amantadine, Apomorphine and Zolpidem in the Treatment of Disorders of Consciousness
Current Pharmaceutical Design Apathy: A Conceptual Review
Current Psychiatry Research and Reviews Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Zolpidem Arousing Effect in Persistent Vegetative State Patients: Autonomic, EEG and Behavioral Assessment
Current Pharmaceutical Design Cognitive Impairment in Depression
Current Psychiatry Reviews The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry Prion Chemical Biology: On the Road to Therapeutics?
Current Topics in Medicinal Chemistry